Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine Plus Thalidomide for Newly Diagnosed CLL
NCT00096018Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- May 2002
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in chronic lymphocytic leukemia (CLL), sponsored by Roswell Park Comprehensive Cancer Center. Started May 2002; status: completed.
02
Drugs
thalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00096018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096018.